PGF and neoplasm: The effect of D16F7 mAb treatment was associated with a strong decrease in the number of PlGF-positive cells, mostly in the bone infiltrate, where the percent decrease of neoplastic PlGF-positive cells was 97% compared to untreated control, whereas in the tumor mass and muscle tissue, the percent reduction was 66 and 71, respectively (Figure 3C,D).